NDC 72606-037 – Stoboclo

Denosumab 60 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC72606-037

Product details

Brand name
Stoboclo
Generic name
Denosumab-bmwo
Labeler
CELLTRION USA, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761404
Marketed since
July 2, 2025
Listing expires
December 31, 2027
Pharmacologic class
RANK Ligand Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Stoboclo →

Package NDC codes (1)

Package NDCDescriptionSince
72606-037-011 SYRINGE in 1 CARTON (72606-037-01) / 1 mL in 1 SYRINGEJul 2, 2025